|
|
||||||||
Technical Briefs |
1
Institut für Klinische Chemie, Molekulare Diagnostik und Mitochondriale Genetik, Academic Hospital München-Schwabing, Kölner Platz 1, 80804 Munich, Germany;
2
P.E. Biosystems, Via Tiepolo, 24, 20052 Monza, Italy;
a author for correspondence: fax 49-(0)89-3068-3911, e-mail Klaus.Gempel@lrz.uni-muenchen.de
The determination of total homocysteine (tHcy) plays an important role in diagnosis and therapy of folate and cobalamin (vitamin B12) deficiencies. In addition, it is now widely accepted that increased tHcy is an independent risk factor for thromboembolism and cardiovascular disease, including coronary occlusive disease (1)(2)(3).
Although the causal role of Hcy in the development of vascular occlusive disease has yet to be determined, prospective intervention trials that will effectively lower total plasma Hcy currently are in progress (4). As a result, various analytical methods have been established to measure tHcy in serum or plasma (5)(6)(7)(8)(9)(10). We have established a more rapid protocol suitable for accurately measuring tHcy in hemolysates by use of liquid chromatography-electrospray ionization-tandem mass spectrometry (LC/MS/MS). The LC/MS/MS method circumvents the disadvantages of time-consuming derivatization and allows the processing of >400 samples per day.
Blood was collected in hemolysate tubes that keep the tHcy
concentration constant for at least 48 h at room temperature
(11). For longer time periods, the hemolysate was stored at
-20 °C. Hemolysate (20 µL) was pipetted onto filter paper
(Neonatal Screening Card; Schleicher & Schuell). For each sample, two
spots (equivalent to 4.7 µL) were punched out and incubated for 15
min at room temperature with a mixture of 20 µL of reducing agent
(500 mmol/L dithiothreitol in doubly distilled water) and of 20 µL
Acknowledgments
References
The following articles in journals at HighWire Press have cited this article:
![]() |
A. Bowron, A. Barton, J. Scott, and D. Stansbie Blood Spot Homocysteine: A Feasibility and Stability Study Clin. Chem., January 1, 2005; 51(1): 257 - 258. [Full Text] [PDF] |
||||
![]() |
T. Arndt, B. Guessregen, A. Hohl, and B. Heicke Total Plasma Homocysteine Measured by Liquid Chromatography-Tandem Mass Spectrometry with Use of 96-Well Plates Clin. Chem., April 1, 2004; 50(4): 755 - 757. [Full Text] [PDF] |
||||
![]() |
H. Refsum, A. D. Smith, P. M. Ueland, E. Nexo, R. Clarke, J. McPartlin, C. Johnston, F. Engbaek, J. Schneede, C. McPartlin, et al. Facts and Recommendations about Total Homocysteine Determinations: An Expert Opinion Clin. Chem., January 1, 2004; 50(1): 3 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Chace, T. A. Kalas, and E. W. Naylor Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns Clin. Chem., November 1, 2003; 49(11): 1797 - 1817. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |